Hyperbilirubinemia in atazanavir treated HIV-infected patients: the impact of the UGT1A1*28 allele

Combination antiretroviral treatment (cART) has significantly improved the life expectancy of people living with HIV. The life-long nature of cART increases the risk of side effects, which in some cases may have been caused by specific genetic characteristics. Patients treated with atazanavir (ATV)...

Descripción completa

Detalles Bibliográficos
Autores principales: Panagopoulos, Periklis, Maltezos, Efstathios, Hatzakis, Angelos, Paraskevis, Dimitrios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5488765/
https://www.ncbi.nlm.nih.gov/pubmed/28790862
http://dx.doi.org/10.2147/PGPM.S107152

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5488765/
https://www.ncbi.nlm.nih.gov/pubmed/28790862
http://dx.doi.org/10.2147/PGPM.S107152

Ejemplares similares